Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | APOBEC3A | P31941 | 4/20 | 0.41 |
| ▸ | APOBEC3G | Q9HC16 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.36 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13688644 | 0.83 | ALDH1A1 (0.42) | LMNAALDH1A1APOBEC3AAPOBEC3GKMT2A | |
| SCHEMBL2112227 | 0.83 | ALDH1A1 (0.59) | LMNAALDH1A1APOBEC3AAPOBEC3GKMT2A | |
| SCHEMBL2234794 | 0.79 | NPSR1 (0.43) | LMNAALDH1A1APOBEC3AAPOBEC3GHPGD | |
| SCHEMBL26348723 | 0.79 | ALDH1A1 (0.39) | LMNAALDH1A1APOBEC3AAPOBEC3GKMT2A | |
| Methylamine SCHEMBL5149607 | 0.78 | APOBEC3A (0.47) | LMNAALDH1A1APOBEC3AAPOBEC3GKMT2A | |
| SCHEMBL5726080 | 0.77 | BCAT2 (0.44) | LMNAAPOBEC3AAPOBEC3GKMT2AMEN1 | |
| SCHEMBL67836 | 0.77 | APOBEC3A (0.50) | LMNAALDH1A1APOBEC3AAPOBEC3GKMT2A | |
| SCHEMBL28226024 | 0.77 | ALDH1A1 (0.39) | LMNAALDH1A1KMT2AMEN1PABPC1 | |
| SCHEMBL28314802 | 0.76 | CYP2C19 (0.43) | LMNAALDH1A1APOBEC3AAPOBEC3GPKM | |
| SCHEMBL13788536 | 0.75 | ALDH1A1 (0.38) | LMNAALDH1A1APOBEC3AAPOBEC3GKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120041061-A | Antibacterial coating, color steel plate and preparation method thereof | 合肥禾盛新型材料有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-120041061-A | Antibacterial coating, color steel plate and preparation method thereof | 合肥禾盛新型材料有限公司 | 2025-05-27 | — | — | CN | disclosed |
| US-20070135454-A1 | Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) | BAYLISS TRACY | 2007-06-14 | — | — | US | disclosed |
| EP-1687306-A1 | BICYCLIC PYRIMIDIN-4-(3H)-ONES AND ANALOGUES AND DERIVATIVES THEREOF WHICH MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) | MERCK SHARP & DOHME LTD. (GB) | 2006-08-09 | — | — | EP | disclosed |
| WO-2005049613-A1 | BICYCLIC PYRIMIDIN-4-(3H)-ONES AND ANALOGUES AND DERIVATIVES THEREOF WHICH MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) | MERCK SHARP & DOHME LIMITED (GB) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135454-A1 | Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) | TRPV1, TRPV2, TRPV4 | LMNA 4257/4885ALDH1A1 825/4885APOBEC3A 4584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.